Significance of platelet function tests;Stellenwert der thrombozytenfunktionsdiagnostik

Internist

Volumn 51, Issue 9, 2010, Pages 1095-1108

  Wolf, Z ^a   Mani, H ^a   Lindhoff Last, E ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Antiplatelet therapy; Bleeding disorders; Platelet aggregometry; Platelet function disorders; Platelet function tests

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; AZLOCILLIN; CEFOTAXIME; CLOPIDOGREL; COLLAGEN; DICLOFENAC; FIBRINOGEN; GLYCOPROTEIN IIB; IBUPROFEN; INDOMETACIN; LATAMOXEF; NAFCILLIN; NAPROXEN; PENICILLIN G; PIPERACILLIN; RISTOCETIN; TICARCILLIN; VON WILLEBRAND FACTOR;

BLOOD CLOTTING PARAMETERS; DIAGNOSTIC VALUE; FUNCTION TEST; HUMAN; MYELOPROLIFERATIVE DISORDER; OUTCOME ASSESSMENT; REVIEW; SCREENING TEST; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VON WILLEBRAND DISEASE;

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELET DISORDERS; COLLAGEN; HEMORRHAGIC DISORDERS; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISTOCETIN; TICLOPIDINE;

EID: 77957768296     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-009-2569-6     Document Type: Review

References (25)

1. Bonello L, Camoin-Jau L, Armero S et al (2009) Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis. Am J Cardiol 103:5-10
2. Born GV (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929
3. Cattaneo M, Lecchi A, Agati B et al (1999) Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Thromb Res 96:213-217
4. Chakroun T, Gerotziafas G, Robert F et al (2004) In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 124:80-85
5. Favaloro EJ (2008) Clinical utility of the PFA-100. Semin Thromb Hemost 34:709-733
6. George JN, Shattil SJ (1991) The clinical importance of acquired abnormalities of platelet function. N Engl J Med 324:27-39
7. Harrison P (2009) Assessment of platelet function in the laboratory. Hamostaseologie 29:25-31
8. Hayward CP, Pai M, Liu Y et al (2009) Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost 7:676-684
9. Hoffman M, Monroe DM III (2001) A cell-based model of hemostasis. Thromb Haemost 85:958-965
10. Koscielny J, Ziemer S, Radtke H et al (2007) Preoperative identification of patients with impaired (primary) haemostasis. A practical concept. Hamostaseologie 27:177-184
11. Linden MD, Frelinger AL III, Barnard MR et al (2004) Application of flow cytometry to platelet disorders. Semin Thromb Hemost 30:501-511
12. Linnemann B, Schwonberg J, Mani H et al (2008) Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost 6:677-683
13. Linnemann B, Schwonberg J, Rechner AR et al (2010) Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y. Ann Hematol 89:597-605
14. Mani H, Kirchmayr K, Klaffling C et al (2004) Influence of blood collection techniques on platelet function. Platelets 15:315-318
15. Mani H, Lindhoff-Last E (2006) Resistance to acetylsalicylic acid and clopidogrel: current status. Hamostaseologie 26:229-238
16. Mani H, Luxembourg B, Klaffling C et al (2005) Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements. J Clin Pathol 58:747-750
17. Maurin N (1999) Rational hemostatic screening. Med Klin (Munich) 94:165-169
18. Nieuwenhuis HK, Akkerman JW, Sixma JJ (1987) Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood 70:620-623
19. Scharf RE (2003) Congenital and acquired platelet function disorders. Hamostaseologie 23:170-180
20. Schmitz G, Rothe G, Ruf A et al (1998) European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 79:885-896
21. Schwarz UR, Geiger J, Walter U, Eigenthaler M (1999) Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets-definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 82:1145-1152
22. Snoep JD, Hovens MM, Eikenboom JC et al (2007) Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 167:1593-1599
23. Snoep JD, Hovens MM, Eikenboom JC et al (2007) Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J 154:221-231
24. Tantry US, Bliden KP, Gurbel PA (2005) Resistance to antiplatelet drugs: current status and future research. Expert Opin Pharmacother 6:2027-2045
25. Wong S, Appleberg M, Ward CM, Lewis DR (2004) Aspirin resistance in cardiovascular disease: a review. Eur J Vasc Endovasc Surg 27:456-465